 BOCA RATON, Florida, Aug. 10, 2021 GLOBE NEWSWIRE -- INmune Bio, Inc. NASDAQ: INMB the Company, a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced that Raymond J. Tesi, MD, President and CEO, will present at the Canaccord Genuity 41st Annual Growth Conference being held August 10 12. 